Fig. 2From: A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungalRepresentative UHPLC–MS/MS chromatograms of zanubrutinib and ibrutinib (IS). (A) blank plasma; (B) a blank plasma sample spiked with LLOQ concentration levels of zanubrutinib and IS; (C) a rat plasma sample obtained 1 h after oral administration of zanubrutinib. The plasma concentration of zanubrutinib was 230 ng/mLBack to article page